Diet drug maker's GlaxoSmithKline's sponsorship of an upcoming PBS program on obesity has raised eyebrows, but PBS says it is following the rules.

According to Broadcasting and Cable.com, Glaxo is underwriting the April broadcast of Fat: What No One is Telling You, the second in the "Take One Step" series of health-related shows and outreach PBS is undertaking in concert with the YMCA.

The series kicked off this week with a show on heart disease, but Glaxo was not a funder, according to a spokeswoman for producer WGBH Boston. But Glaxo is underwriting the "Fat" show, which debuts April 11.

PBS says there is no conflict because it notes where the funding comes from and can't help it that the drug maker recently got FDA approval to take its obesity drug, Alli, over the counter.

Check out the full article and see what you think. And while you're at it, have a look at GlaxoSmithKline's presentation on obesity.

-- Amanda Barrett, amNY.com